When a company receives a major order for its products then it almost always comes as a boost for its stock and that is what happened with the CytoDyn Inc (OTCMKTS:CYDY) stock last week.
Last week the stock ended up making gains of as much as 10% after the company bagged a purchase order from for its COVID 19 medicine leronlimab from the Philippines company Chiral Pharma Corporation. The order was placed by Chiral Pharma under the provision of Compassionate Special Permit that is related to treatment of COVID 19 patients in Philippines.
This is a major boost to the company and the reaction in the markets was understandable. In this regard, it is also necessary to note that CytoDyn had earlier provided the product to the first 100 critically ill COVID 19 patients in the Philippines. It now remains to be seen if leronlimab manages to be a success in the country in the coming weeks.
Moving Averages
| +/- EMA(20) | 2.25 (-6.67%) |
| +/- SMA(50) | 2.72 (-22.79%) |
| +/- SMA(200) | 3.53 (-40.51%) |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
| Classic | 1.8833 | 1.9667 | 2.0333 | 2.1167 | 2.1833 | 2.2667 | 2.3333 |
| Fibonacci | 1.9667 | 2.0240 | 2.0594 | 2.1167 | 2.1740 | 2.2094 | 2.2667 |
| Camarilla | 2.0587 | 2.0725 | 2.0862 | 2.1167 | 2.1137 | 2.1275 | 2.1412 |
| Woodie | 1.8850 | 1.9675 | 2.0350 | 2.1175 | 2.1850 | 2.2675 | 2.3350 |
 Stock Attempts To Bounce Back: Will it Sustain?){kind=link}